NCT03181074View on ClinicalTrials.gov

Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

October 21, 2015

Primary Completion Date

August 19, 2019

Study Completion Date

August 19, 2019

Conditions
Hepatitis C
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (2)

14050

Local Institution, Mexico City

03900

Local Institution, Benito Juárez

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03181074 - Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults | Biotech Hunter | Biotech Hunter